Jeffrey Wang, MD
Vascular Surgery · Germantown, MDNPI 1871771808
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 62.1% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2019 at $38,976 and has fallen 96.5% since, to $1,352 in 2025. Among vascular surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $182.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$33K
- Cardiovascular Systems Inc.$8K
- Johnson & Johnson$3K
- W. L. Gore & Associates, Inc.$3K
- Medtronic$1K
- Cook Medical LLC$1K
- plus $4K from 29 others
Across 10 payments — averaging $2094.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$12K
- Cook Research Incorporated$8K
- Cardiovascular Systems Inc.$1K
What the payments were for
- Consulting fees$5001%
- Speaking & faculty fees$27,11651%
- Travel & lodging$13,23125%
- Food & beverage$12,45323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 39 | $33,112 |
| Cardiovascular Systems Inc. | 29 | $8,101 |
| Johnson & Johnson | 10 | $3,232 |
| W. L. Gore & Associates, Inc. | 55 | $2,758 |
| Medtronic(2 entities) | 34 | $1,333 |
| Cook Medical LLC | 33 | $1,004 |
| Philips North America LLC | 10 | $408 |
| Inari Medical, Inc. | 5 | $362 |
| Cordis US CORP. | 7 | $287 |
| Terumo Medical Corporation | 8 | $275 |
| Shockwave Medical, Inc | 6 | $261 |
| Cardinal Health 200 LLC | 6 | $250 |
| Tactile Systems Technology Inc | 9 | $250 |
| Penumbra, Inc. | 2 | $248 |
| Smith+Nephew | 7 | $207 |
| Kerecis Limited | 1 | $187 |
| Angiodynamics, Inc. | 2 | $152 |
| Limflow Inc. | 1 | $146 |
| Silk Road Medical, Inc. | 5 | $127 |
| Abbott | 1 | $88 |
| Misonix Inc | 1 | $81 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Bard Peripheral Vascular, Inc. | 3 | $65 |
| Amgen | 1 | $47 |
| Pfizer | 2 | $37 |
| Okami Medical, Inc. | 1 | $34 |
| Argon Medical Devices, Inc. | 1 | $25 |
| TEI Medical Inc. | 1 | $23 |
| Biocompatibles, Inc. | 1 | $22 |
| Livanova USA, Inc. | 1 | $22 |
| Axogen | 1 | $20 |
| Medline Industries LP | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $14 |
| Bolton Medical Inc | 1 | $14 |
| Surmodics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANGIOJET$20,441
- GENERAL - THERAPIES$11,623
- Diamondback Peripheral$6,987
- XARELTO$3,055
- Peripheral Orbital Atherectomy System$677
- Kerecis Omega3 SurgiClose$562
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$480
- GORE VIABAHN Endoprosthesis with Heparin$390
- Kerecis Omega3 GraftGuide$187
- Kerecis Omega3 Marigen$187
- MyCareLink$161
- EXCLUDER AAA Endoprosthesis$152
- LIMFLOW SYSTEM$146
- GORE VIABAHN VBX Balloon Expandable Endo$140
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$140
- Flexitouch Plus$138
- Nimbl$138
- NANOCROSS ELITE$130
- Endurant$129
- Indigo System$127
How this compares
$53,300 in reported general payments places this provider in the 95th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $75,886 |
| BrilintaTicagrelor | 108 | $74,917 |
| XareltoRivaroxaban | 62 | $61,426 |
| ClopidogrelClopidogrel Bisulfate | 355 | $6,438 |
| Cilostazol | 39 | $1,752 |
| Prasugrel Hcl | 14 | $979 |
| Prednisone | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $75,88670 claims |
| Johnson & JohnsonXarelto | $3,232 | $61,42662 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Germantown
- Dustin YoonGermantown$36K
- Shan E Ali HaiderGermantown$3K
- Richard SilvaGermantown$2K
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Michael OsgoodBel Air$57K
- Frank CriadoBaltimore$52K
- Micah GirottiBel Air$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.